These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1693566)
1. Inhibitory effects of the bone-derived growth factors osteoinductive factor and transforming growth factor-beta on isolated osteoclasts. Oreffo RO; Bonewald L; Kukita A; Garrett IR; Seyedin SM; Rosen D; Mundy GR Endocrinology; 1990 Jun; 126(6):3069-75. PubMed ID: 1693566 [TBL] [Abstract][Full Text] [Related]
2. Osteoinductive factor inhibits formation of human osteoclast-like cells. Kukita A; Bonewald L; Rosen D; Seyedin S; Mundy GR; Roodman GD Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3023-6. PubMed ID: 2326263 [TBL] [Abstract][Full Text] [Related]
3. Biphasic effects of transforming growth factor-beta on the production of osteoclast-like cells in mouse bone marrow cultures: the role of prostaglandins in the generation of these cells. Shinar DM; Rodan GA Endocrinology; 1990 Jun; 126(6):3153-8. PubMed ID: 2161750 [TBL] [Abstract][Full Text] [Related]
4. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Hill PA; Reynolds JJ; Meikle MC Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521 [TBL] [Abstract][Full Text] [Related]
5. Differences in the fusion and resorption activity of human osteoclasts after stimulation with different growth factors released from a polylactide carrier. Wildemann B; Kadow-Romacker A; Lübberstedt M; Raschke M; Haas NP; Schmidmaier G Calcif Tissue Int; 2005 Jan; 76(1):50-5. PubMed ID: 15477999 [TBL] [Abstract][Full Text] [Related]
6. Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone. Dodds RA; Connor JR; James IE; Rykaczewski EL; Appelbaum E; Dul E; Gowen M J Bone Miner Res; 1995 Nov; 10(11):1666-80. PubMed ID: 8592943 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts. Yates AJ; Oreffo RO; Mayor K; Mundy GR J Bone Miner Res; 1991 May; 6(5):473-8. PubMed ID: 2068953 [TBL] [Abstract][Full Text] [Related]
8. Role of transforming growth factor-beta in bone remodeling. Bonewald LF; Mundy GR Clin Orthop Relat Res; 1990 Jan; (250):261-76. PubMed ID: 2403492 [TBL] [Abstract][Full Text] [Related]
9. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity. Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709 [TBL] [Abstract][Full Text] [Related]
10. Osteoclast synthesis and secretion and activation of latent transforming growth factor beta. Oursler MJ J Bone Miner Res; 1994 Apr; 9(4):443-52. PubMed ID: 8030431 [TBL] [Abstract][Full Text] [Related]
11. Nitroblue tetrazolium reduction and bone resorption by osteoclasts in vitro inhibited by a manganese-based superoxide dismutase mimic. Ries WL; Key LL; Rodriguiz RM J Bone Miner Res; 1992 Aug; 7(8):931-9. PubMed ID: 1442207 [TBL] [Abstract][Full Text] [Related]
12. Osteoblast proliferation and differentiation on dentin slices are modulated by pretreatment of the surface with tetracycline or osteoclasts. Schwartz Z; Lohmann CH; Wieland M; Cochran DL; Dean DD; Textor M; Bonewald LF; Boyan BD J Periodontol; 2000 Apr; 71(4):586-97. PubMed ID: 10807123 [TBL] [Abstract][Full Text] [Related]
13. The cellular actions of interleukin-11 on bone resorption in vitro. Hill PA; Tumber A; Papaioannou S; Meikle MC Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935 [TBL] [Abstract][Full Text] [Related]
14. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. Garrett IR; Boyce BF; Oreffo RO; Bonewald L; Poser J; Mundy GR J Clin Invest; 1990 Mar; 85(3):632-9. PubMed ID: 2312718 [TBL] [Abstract][Full Text] [Related]
15. Generation of osteoclastic function in mouse bone marrow cultures: multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for osteoclastic differentiation. Hattersley G; Chambers TJ Endocrinology; 1989 Apr; 124(4):1689-96. PubMed ID: 2924719 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of avian osteoclast bone resorption by monoclonal antibody 121F: a mechanism involving the osteoclast free radical system. Collin-Osdoby P; Li L; Rothe L; Anderson F; Kirsch D; Oursler MJ; Osdoby P J Bone Miner Res; 1998 Jan; 13(1):67-78. PubMed ID: 9443792 [TBL] [Abstract][Full Text] [Related]
17. Inhibiting and stimulating effects of TGF-beta 1 on osteoclastic bone resorption in fetal mouse bone organ cultures. Dieudonné SC; Foo P; van Zoelen EJ; Burger EH J Bone Miner Res; 1991 May; 6(5):479-87. PubMed ID: 2068954 [TBL] [Abstract][Full Text] [Related]
18. Effects of TGF-beta 2 on mineral resorption in cultured embryonic mouse long bones; 45Ca release and osteoclast differentiation and migration. Berghuis HM; Dieudonné SC; Goei W; Veldhuijzen JP Eur J Orthod; 1994 Apr; 16(2):130-7. PubMed ID: 8005200 [TBL] [Abstract][Full Text] [Related]
19. An assay system utilizing devitalized bone for assessment of differentiation of osteoclast progenitors. Amano S; Hanazawa S; Kawata Y; Ohta K; Kitami H; Kitano S J Bone Miner Res; 1992 Mar; 7(3):321-8. PubMed ID: 1585834 [TBL] [Abstract][Full Text] [Related]
20. Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. Oreffo RO; Mundy GR; Seyedin SM; Bonewald LF Biochem Biophys Res Commun; 1989 Feb; 158(3):817-23. PubMed ID: 2920041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]